welcome
NBC News

NBC News

Health

Health

Advanced colon cancer patients lived twice as long with a Pfizer combo therapy, trial finds

NBC News
Summary
Nutrition label

85% Informative

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer.

The three -treatment combination included a standard chemotherapy drug, an antibody drug called cetuximab and a pill from Pfizer called Braftovi .

The Food and Drug Administration granted the treatment fast-track approval as a first -line approach in December .

VR Score

90

Informative language

93

Neutral language

16

Article tone

semi-formal

Language

English

Language complexity

58

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links